Today our team joined @senatorblakespear and Neurocrine Biosciences at the California State Capitol for Tardive Dyskinesia (TD) Awareness Week! We’re glad to be recognized through SCR 68, which officially declares the week of May 5, 2025, as Tardive Dyskinesia Awareness Week in California. This important resolution helps shine a light on TD, a serious and often misunderstood condition linked to long-term use of antipsychotic medications. Mental Health America of California remains committed to continuing our advocacy and education efforts to ensure proactive detection, diagnosis, and care for those affected by drug-induced movement disorders like Tardive Dyskinesia (TD). #TDAwareness #MentalHealthMatters #SCR68 #TardiveDyskinesia #MentalHealthAwareness (fb)

Thank you to @senatorblakespear and Neurocrine Biosciences for recognizing our team at Mental Health America of California during Tardive Dyskinesia (TD) Awareness Week. We're honored to be recognized through SCR 68, which officially declares the week of May 5, 2025, as Tardive Dyskinesia Awareness Week in California. This important resolution helps shine a light on TD, a serious and often misunderstood condition linked to long-term use of antipsychotic medications. Each year, 1 in 20 U.S. adults experiences a serious mental illness. It's vital that individuals taking antipsychotic medications are regularly monitored for movement disorders like TD, allowing for earlier recognition and treatment. At Mental Health America of California, we're committed to continuing our advocacy and education efforts to ensure proactive detection, diagnosis, and care for those affected by drug-induced movement disorders like TD. #TDAwareness #MentalHealthMatters #SCR68 #TardiveDyskinesia #MentalHealthAwareness (fb)